Immuno-Biological Laboratories Inc is categorized under in Minneapolis, MN and active since 1997.
Immuno-Biological Laboratories Inc was established in 1997, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 423450 by the NAICS.
If you are seeking more information, feel free to contact Mark Kowal at the company’s single location by writing to 8201 Central Avenue Ne # P, Minneapolis, Minnesota MN 55432 or by phoning (763) 780-2955. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Immuno-Biological Laboratories Inc |
| Contact Person: | Mark Kowal |
| Address: | 8201 Central Avenue Ne # P, Minneapolis, Minnesota 55432 |
| Phone Number: | (763) 780-2955 |
| Website Address: | kmidiagnostics.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | |
| SIC Code: | 5047 |
| NAICS Code: | 423450 |
| Share This Business: |
Immuno-Biological Laboratories Inc was started in 1997 to provide professional under the SIC code 5047 and NAICS code 423450. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Mark Kowal for inquiries that concern Immuno-Biological Laboratories Inc by calling the company number (763) 780-2955, as your correspondence is most welcome. Additionally, the physical location of the single location of Immuno-Biological Laboratories Inc can be found at the coordinates 45.115125,-93.237884 as well as the street address 8201 Central Avenue Ne # P in Minneapolis, Minnesota 55432.
For its online presence, you may visit Immuno-Biological Laboratories Inc’s website at kmidiagnostics.com and engage with its social media outlets through on Twitter and on Facebook.